News
2025.11.12
#1 - What is behind the current resurgence in measles?
Insufficient vaccine coverage.
At the end of April 2025, WHO, UNICEF and Gavi, the Vaccine Alliance,...
Vidéo
2025.05.22
Measles wipes out our immunity!
Yasmine Belkaid, Director General of the Institut Pasteur, sounds the alarm during her appearance on Lundis du 1: measles is...
Vidéo
2025.04.07
Measles explodes in 2025: what do we do?
Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory...
News
2024.05.29
Oncovita and the Institut Pasteur have already been working together for several years on the construction and development of new vaccines based on MeasovirR...
News
2022.08.05
RNA viruses, which include influenza viruses, SARS-CoV-2 (which causes COVID-19) and HIV, are one of the major threats that the immune system has to deal...
News
2022.05.20
New genetic analyses of Latin Americans have revealed numerous insights into how indigenous peoples evolved before European contact, and how their genetics...
News
2023.11.27
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030...
News
2023.06.16
In January 2018, Institut Pasteur adopted a new strategic plan for 2019-2023, to boost basic research and increase its impact on human health, with...
News
2023.01.06
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses circulating in South America and tested it...
Document de presse
2021.01.25
Since early 2020, the Institut Pasteur has been engaged in research in several of its areas of scientific expertise, including virology, diagnostics,...